A novel approach targeting persistent immune dysfunction in PTLDS patients marks a significant step forward in addressing...
Layla Zulfa
Oklahoma City, OK – In a significant stride for cancer research, scientists at the University of Oklahoma...
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged...
NORMAN, OK – In a significant stride toward understanding and potentially combating one of the most aggressive...
OTTAWA – While the ringing of the "end-of-treatment" bell is often celebrated as a final victory over...
In an era defined by the rapid proliferation of digital information, a paradoxical crisis persists: the global...
HOUSTON – In a landmark development for the field of reconstructive and aesthetic medicine, Lynn A. Damitz,...
For decades, the European continent has been the bedrock of oncology innovation. From the discovery of foundational...
In a landmark shift aimed at modernizing the regulatory landscape for orphan drug development, the U.S. Food...
Norman, OK – In a significant stride towards understanding and potentially treating one of the most aggressive...
